Prednisone pluscabazitaxel ormitoxantrone formetastaticcastration-resistantprostate cancerprogressing afterdocetaxel treatment Johann S. de BonoStéphane OudardMustafa Özgüroğlu2010 год

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
статья из журнала